2-Oxoindoline-based hydroxamic acids: novel HDAC inhibitors with promising anticancer activity.

Huong TTL, Kim HK, Thai NA, Anh DP, Thao NTP, Ngan NP, Thang NQ, Kang DH, Kim HY, Kang JS, Anh DT, Tung TT, Han SB, Nam NH

Open source

DOI: 10.1039/d6ra04679g
Published: 2026 Aug 12
Container: RSC advances
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1039/d6ra04679g,
  title = {2-Oxoindoline-based hydroxamic acids: novel HDAC inhibitors with promising anticancer activity.},
  author = {Huong TTL and Kim HK and Thai NA and Anh DP and Thao NTP and Ngan NP and Thang NQ and Kang DH and Kim HY and Kang JS and Anh DT and Tung TT and Han SB and Nam NH},
  year = {2026},
  journal = {RSC advances},
  doi = {10.1039/d6ra04679g},
  url = {https://doi.org/10.1039/d6ra04679g}
}

RIS

TY  - JOUR
TI  - 2-Oxoindoline-based hydroxamic acids: novel HDAC inhibitors with promising anticancer activity.
AU  - Huong TTL
AU  - Kim HK
AU  - Thai NA
AU  - Anh DP
AU  - Thao NTP
AU  - Ngan NP
AU  - Thang NQ
AU  - Kang DH
AU  - Kim HY
AU  - Kang JS
AU  - Anh DT
AU  - Tung TT
AU  - Han SB
AU  - Nam NH
PY  - 2026
JO  - RSC advances
DO  - 10.1039/d6ra04679g
UR  - https://doi.org/10.1039/d6ra04679g
ER  -

APA

TTL, H., HK, K., NA, T., DP, A., NTP, T., NP, N., NQ, T., DH, K., HY, K., JS, K., DT, A., TT, T., SB, H., & NH, N. (2026). 2-Oxoindoline-based hydroxamic acids: novel HDAC inhibitors with promising anticancer activity.. RSC advances. https://doi.org/10.1039/d6ra04679g

Source records

pubmed · retrieved 2026-09-26T00:10:01.627Z